Cyclic adenosine monophosphate and cardiac contractility.
D000227:Adenine Nucleotides / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000378:metabolism; D001665:Binding Sites; D002395:Catecholamines / Q000378:metabolism / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism / Q000502:physiology*; D006003:Glycogen / Q000378:metabolism; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism; D010085:Oxidative Phosphorylation; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D006005:Phosphorylases / Q000378:metabolism; D011485:Protein Binding; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology
D000227:Adenine Nucleotides; D002395:Catecholamines; D010726:Phosphodiesterase Inhibitors; D006003:Glycogen; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D006005:Phosphorylases; D000262:Adenylyl Cyclases